These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8809141)

  • 1. Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptides.
    Hellmark T; Brunmark C; Trojnar J; Wieslander J
    Clin Exp Immunol; 1996 Sep; 105(3):504-10. PubMed ID: 8809141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptides of Goodpasture's antigen in antiglomerular basement membrane nephritis in rats.
    Luo AM; Fox JW; Chen L; Bolton WK
    J Lab Clin Med; 2002 May; 139(5):303-10. PubMed ID: 12032491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
    Savige JA; Gallicchio M
    Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome.
    Hellmark T; Johansson C; Wieslander J
    Kidney Int; 1994 Sep; 46(3):823-9. PubMed ID: 7527877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
    Brainwood D; Kashtan C; Gubler MC; Turner AN
    Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
    Pedchenko V; Bondar O; Fogo AB; Vanacore R; Voziyan P; Kitching AR; Wieslander J; Kashtan C; Borza DB; Neilson EG; Wilson CB; Hudson BG
    N Engl J Med; 2010 Jul; 363(4):343-54. PubMed ID: 20660402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome.
    Kalluri R; Wilson CB; Weber M; Gunwar S; Chonko AM; Neilson EG; Hudson BG
    J Am Soc Nephrol; 1995 Oct; 6(4):1178-85. PubMed ID: 8589284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen restriction and IgG subclasses among anti-GBM autoantibodies.
    Segelmark M; Butkowski R; Wieslander J
    Nephrol Dial Transplant; 1990; 5(12):991-6. PubMed ID: 2128958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goodpasture syndrome. Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the alpha 3(IV) chain of basement membrane collagen.
    Kalluri R; Gunwar S; Reeders ST; Morrison KC; Mariyama M; Ebner KE; Noelken ME; Hudson BG
    J Biol Chem; 1991 Dec; 266(35):24018-24. PubMed ID: 1721062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
    Borza DB; Hudson BG
    Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
    Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
    J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of an ELISA for Goodpasture's disease based on sheep alpha 3(IV)NC1 domains.
    Katbamna I; Turner N; Ross CN; Pusey CD
    J Clin Lab Immunol; 1995; 47(1):11-24. PubMed ID: 8735432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different immunologic properties of the globular NC1 domain of collagen type IV isolated from various human basement membranes.
    Weber M; Pullig O
    Eur J Clin Invest; 1992 Feb; 22(2):138-46. PubMed ID: 1374033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
    Ryan JJ; Mason PJ; Pusey CD; Turner N
    Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of EHS type IV collagen lacking Goodpasture's epitope in glomerulonephritis in rats.
    Bolton WK; Luo AM; Fox PL; May WJ; Sturgill BC
    Kidney Int; 1995 Feb; 47(2):404-10. PubMed ID: 7536854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen.
    Kalluri R; Sun MJ; Hudson BG; Neilson EG
    J Biol Chem; 1996 Apr; 271(15):9062-8. PubMed ID: 8621555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epitope mapping of anti-glomerular basement membrane antibodies].
    Ding J; Zhao M; Wang H
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):863-5. PubMed ID: 11702682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies.
    Hellmark T; Burkhardt H; Wieslander J
    J Biol Chem; 1999 Sep; 274(36):25862-8. PubMed ID: 10464328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Goodpasture's epitope in development of experimental autoimmune glomerulonephritis in rats.
    Bolton WK; Luo AM; Fox P; May W; Fox J
    Kidney Int; 1996 Feb; 49(2):327-34. PubMed ID: 8821814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of critical residues of linear B cell epitope on Goodpasture autoantigen.
    Jia XY; Cui Z; Li JN; Hu SY; Zhao MH
    PLoS One; 2015; 10(4):e0123277. PubMed ID: 25874890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.